Literature DB >> 23249649

MRI-monitored transcatheter intra-arterial delivery of SPIO-labeled natural killer cells to hepatocellular carcinoma: preclinical studies in a rodent model.

Alexander Y Sheu1, Zhuoli Zhang, Reed A Omary, Andrew C Larson.   

Abstract

OBJECTIVES: The objective of this study was to test the hypotheses that intra-arterial infusion allows for targeted natural killer (NK) lymphocyte delivery to hepatocellular carcinoma (HCC) and that iron oxide labeling allows for quantitative visualization of intra-arterial NK delivery with magnetic resonance imaging (MRI).
MATERIALS AND METHODS: Experiments received approval from the institutional animal care and use committee. NK-92MI cells were labeled with superparamagnetic iron oxide (SPIO) nanoparticles. Cell viability, labeling efficacy, and cell phantom imaging studies were performed. Eighteen rats were each implanted with HCC tumors. Catheter was placed in proper hepatic artery for either NK lymphocyte (12 rats) or saline (6 rats) infusion. For the 6 rats, MRI T2* measurements for tumor and normal liver were compared before and after the NK infusion and correlated with histologic measurements. Prussian blue staining was used for labeled NK identification. The remaining rats survived for 8 days after the infusion to compare tumor size changes in the rats that received NK cell (6 rats) or saline (6 rats) infusions. Spearman correlation coefficients and t tests were calculated for statistical analyses.
RESULTS: Increasing SPIO incubation concentration decreased cell viability. Labeling efficacy mean (SD) was 88.0% (3.1%) across samples. The spatial extent of T2*-weighted contrast and R2* relaxivity values increased for cell phantom samples incubated with increasing SPIO concentrations. T2* measurements decreased in the tumor and normal liver tissues after the NK infusion (P < 0.001); ΔT2* was greater in the tumors than in the normal liver tissue (P < 0.001). Histologic measurements demonstrated increased NK delivery to the tumor compared with the normal liver (P < 0.001). ΔT2* was well correlated with histologic NK measurements (ρ = 0.70). Changes in tumor diameter 8 days after the infusion were significantly different between those rats that received NK cell infusions (-2.49 [0.86] mm) and those that received sham saline infusion (5.23 [0.66] mm).
CONCLUSIONS: Intra-arterial infusion permitted selective delivery of NK cells to HCC. Transcatheter delivery of SPIO-labeled NK cells can be quantitatively visualized with MRI. Transcatheter NK cell delivery limited tumor size progression compared with controls.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23249649      PMCID: PMC3644319          DOI: 10.1097/RLI.0b013e31827994e5

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  22 in total

1.  Migration of iron oxide-labeled human hematopoietic progenitor cells in a mouse model: in vivo monitoring with 1.5-T MR imaging equipment.

Authors:  Heike E Daldrup-Link; Martina Rudelius; Guido Piontek; Stephan Metz; Rosalinde Bräuer; Gerlinde Debus; Claire Corot; Jürgen Schlegel; Thomas M Link; Christian Peschel; Ernst J Rummeny; Robert A J Oostendorp
Journal:  Radiology       Date:  2005-01       Impact factor: 11.105

2.  A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization.

Authors:  R J Lewandowski; L M Kulik; A Riaz; S Senthilnathan; M F Mulcahy; R K Ryu; S M Ibrahim; K T Sato; T Baker; F H Miller; R Omary; M Abecassis; R Salem
Journal:  Am J Transplant       Date:  2009-06-22       Impact factor: 8.086

3.  Characterization of genetically altered, interleukin 2-independent natural killer cell lines suitable for adoptive cellular immunotherapy.

Authors:  Y K Tam; G Maki; B Miyagawa; B Hennemann; T Tonn; H G Klingemann
Journal:  Hum Gene Ther       Date:  1999-05-20       Impact factor: 5.695

Review 4.  Monitoring of natural killer cell immunotherapy using noninvasive imaging modalities.

Authors:  Priyanka Jha; Daniel Golovko; Sukhmine Bains; Daniel Hostetter; Reinhard Meier; Michael F Wendland; Heike E Daldrup-Link
Journal:  Cancer Res       Date:  2010-07-14       Impact factor: 12.701

5.  Comparison of transcatheter intraarterial perfusion MR imaging and fluorescent microsphere perfusion measurements during transcatheter arterial embolization of rabbit liver tumors.

Authors:  Sumeet Virmani; Dingxin Wang; Kathleen R Harris; Robert K Ryu; Kent T Sato; Robert J Lewandowski; Albert A Nemcek; Barbara Szolc-Kowalska; Gayle Woloschak; Riad Salem; Andrew C Larson; Reed A Omary
Journal:  J Vasc Interv Radiol       Date:  2007-10       Impact factor: 3.464

6.  Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents.

Authors:  Joseph A Frank; Brad R Miller; Ali S Arbab; Holly A Zywicke; E Kay Jordan; Bobbi K Lewis; L Henry Bryant; Jeff W M Bulte
Journal:  Radiology       Date:  2003-06-20       Impact factor: 11.105

7.  Depressed natural killer cell activity in patients with hepatocellular carcinoma. In vitro effects of interferon and levamisole.

Authors:  K Son; M Kew; A R Rabson
Journal:  Cancer       Date:  1982-12-15       Impact factor: 6.860

8.  In vitro characterization of two different ultrasmall iron oxide particles for magnetic resonance cell tracking.

Authors:  Gerrit Fleige; Florian Seeberger; Daniela Laux; Mayk Kresse; Matthias Taupitz; Herbert Pilgrimm; Claus Zimmer
Journal:  Invest Radiol       Date:  2002-09       Impact factor: 6.016

9.  Preferential localization of human adherent lymphokine-activated killer cells in tumor microcirculation.

Authors:  A Sasaki; R J Melder; T L Whiteside; R B Herberman; R K Jain
Journal:  J Natl Cancer Inst       Date:  1991-03-20       Impact factor: 13.506

10.  Carbogen gas-challenge BOLD MR imaging in a rat model of diethylnitrosamine-induced liver fibrosis.

Authors:  Ning Jin; Jie Deng; Tamuna Chadashvili; Yue Zhang; Yang Guo; Zhuoli Zhang; Guang-Yu Yang; Reed A Omary; Andrew C Larson
Journal:  Radiology       Date:  2010-01       Impact factor: 11.105

View more
  18 in total

1.  MR imaging enables measurement of therapeutic nanoparticle uptake in rat N1-S1 liver tumors after nanoablation.

Authors:  Joseph L McDevitt; Samdeep K Mouli; Patrick D Tyler; Weiguo Li; Jodi Nicolai; Daniele Procissi; Ann B Ragin; Y Andrew Wang; Robert J Lewandowski; Riad Salem; Andrew C Larson; Reed A Omary
Journal:  J Vasc Interv Radiol       Date:  2014-05-20       Impact factor: 3.464

Review 2.  Immunological effects of iron oxide nanoparticles and iron-based complex drug formulations: Therapeutic benefits, toxicity, mechanistic insights, and translational considerations.

Authors:  Ankit Shah; Marina A Dobrovolskaia
Journal:  Nanomedicine       Date:  2018-02-02       Impact factor: 5.307

3.  Real-time MRI for precise and predictable intra-arterial stem cell delivery to the central nervous system.

Authors:  Piotr Walczak; Joanna Wojtkiewicz; Adam Nowakowski; Aleksandra Habich; Piotr Holak; Jiadi Xu; Zbigniew Adamiak; Moussa Chehade; Monica S Pearl; Philippe Gailloud; Barbara Lukomska; Wojciech Maksymowicz; Jeff Wm Bulte; Miroslaw Janowski
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

4.  Clinically applicable magnetic-labeling of natural killer cells for MRI of transcatheter delivery to liver tumors: preclinical validation for clinical translation.

Authors:  Kangan Li; Andrew C Gordon; Linfeng Zheng; Weiguo Li; Yang Guo; Jing Sun; Guixiang Zhang; Guohong Han; Andrew C Larson; Zhuoli Zhang
Journal:  Nanomedicine (Lond)       Date:  2015       Impact factor: 5.307

5.  (19)F-MRI for monitoring human NK cells in vivo.

Authors:  Myriam N Bouchlaka; Kai D Ludwig; Jeremy W Gordon; Matthew P Kutz; Bryan P Bednarz; Sean B Fain; Christian M Capitini
Journal:  Oncoimmunology       Date:  2016-02-18       Impact factor: 8.110

6.  HSP70/IL-2 Treated NK Cells Effectively Cross the Blood Brain Barrier and Target Tumor Cells in a Rat Model of Induced Glioblastoma Multiforme (GBM).

Authors:  Farzaneh Sharifzad; Soura Mardpour; Saeid Mardpour; Esmaeil Fakharian; Adeleh Taghikhani; Amirhossein Sharifzad; Sahar Kiani; Yasaman Heydarian; Marek J Łos; Zahra Azizi; Saeid Ghavami; Amir Ali Hamidieh; Marzieh Ebrahimi
Journal:  Int J Mol Sci       Date:  2020-03-25       Impact factor: 5.923

Review 7.  Nanotechnology synergized immunoengineering for cancer.

Authors:  Deepak S Chauhan; Anupam Dhasmana; Partha Laskar; Rajendra Prasad; Nishant K Jain; Rohit Srivastava; Meena Jaggi; Subhash C Chauhan; Murali M Yallapu
Journal:  Eur J Pharm Biopharm       Date:  2021-03-24       Impact factor: 5.589

Review 8.  Molecular magnetic resonance imaging in cancer.

Authors:  Mohammad Haris; Santosh K Yadav; Arshi Rizwan; Anup Singh; Ena Wang; Hari Hariharan; Ravinder Reddy; Francesco M Marincola
Journal:  J Transl Med       Date:  2015-09-23       Impact factor: 5.531

Review 9.  In vivo monitoring of natural killer cell trafficking during tumor immunotherapy.

Authors:  Naomi S Sta Maria; Samuel R Barnes; Russell E Jacobs
Journal:  Magn Reson Insights       Date:  2014-06-05

Review 10.  Iron oxide nanoparticles for immune cell labeling and cancer immunotherapy.

Authors:  Seokhwan Chung; Richard A Revia; Miqin Zhang
Journal:  Nanoscale Horiz       Date:  2021-07-20       Impact factor: 11.684

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.